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Abstract
Background: Meningiomas are the most commonly occurring intracranial tumors and account for approximately 15220%
of central nervous system tumors. Surgery and radiation therapy is a common treatment for brain tumors, however, patients
whose tumors recur after such treatments have limited therapeutic options. Earlier studies have reported important roles of
uPA, uPAR and cathepsin B in tumor progression.
Methodology/Principal Findings: In the present study, we examined the therapeutic significance of RNAi-mediated
simultaneous down regulation of these proteolytic networks using two bicistronic siRNA constructs, pUC (uPAR/cathepsin
B) and pU2 (uPA/uPAR) either alone or in combination with radiation in two different meningioma cell lines. Transfection of
meningioma cells with pUC and pU2 significantly reduced angiogenesis as compared to control treatment both in vitro and
in vivo nude mice model. This effect is mediated by inhibiting angiogenic molecules (Ang-1, Ang-2 and VEGF). Expression of
focal adhesion kinase (FAK) is elevated in malignant meningioma, yet the role of intrinsic FAK activity in promoting tumor
progression remains undefined. We found that pUC treatment reduced FAK phosphorylation at Y925 more efficiently
compared to pU2 treatment. In immunoprecipitation assay, we found pronounced reduction of FAK (Y925) interaction with
Grb2 in meningioma cells transfected with pUC with and without irradiation. Transient over-expression of uPAR and
cathepsin B by full length uPAR/cathepsin B (FLpU/C) in pUC transfected meningioma cells promoted vascular phenotype,
rescued expression of Ang-1, Ang-2, VEGF, FAK (Y925) and Grb2 both in vitro and in vivo mice model.
Conclusion/Significance: These studies provide the first direct proof that bicistronic siRNA construct for uPAR and
cathepsin B (pUC) reduces Y925-FAK activity and this inhibition is rescued by overexpression of both uPAR and cathepsin B
which clearly demonstrates that pUC could thus be a potential therapeutic approach as an anti-angiogenic agent in
meningioma.
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Introduction
Meningiomas are the second most common primary tumor of the
centralnervoussystem,arisingfromthearachnoidal‘‘cap’’cellsinthe
meninges. They constitute ,20% of all intracranial primary brain
tumors and are more frequent in females [1]. Most meningiomas are
effectively addressed by surgical resection and radiation therapy,
which is a common treatment for brain tumors. Ionizing radiation
can elicit an activated phenotype that promotes rapid and persistent
remodeling of the extracellular matrix (ECM) through the induction
of proteases such as uPA, uPAR, and cathepsin B which suggests that
inhibition of these molecules could be a potential therapeutic
approach to improve the efficacy of radiotherapy [2,3].
Expression of proteolytic parameters of the urokinase-type plasmin-
ogen activator system (uPA, uPAR), and cathepsin B have been proven
to be an independent prognostic parameter in cancer. These
proteolytic cascades, once modified, assist several aspects of tumori-
genesis. It has been shown that the content of some tumor-associated
proteolytic factors in tumor extracts have a strong prognostic value.
Previous studies performed by our group have established uPA, uPAR
and cathepsin B as potential targets for therapeutic treatment of
glioblastoma [4,5]. These proteolytic pathways activate a network of
interconnected cell-signaling pathways that regulate cell proliferation,
survival, migration and angiogenesis [6–9]. Several earlier studies have
revealed that these proteolytic networks play affirmative roles in various
aspects of tumorigenesis [9]. Our investigation uses this approach to
examine the therapeutic significance of RNAi-mediated simultaneous
down regulation of these proteolytic networks in combination with
irradiation in malignant meningiomas.
As a result of uPA, uPAR and cathepsin B, interactions with
certain proteins may activate intracellular signaling molecules such
as focal adhesion kinase (FAK). Focal adhesion kinase (FAK) is an
PLoS ONE | www.plosone.org 1 February 2011 | Volume 6 | Issue 2 | e17123intracellular protein-tyrosine kinase, the activity of which is
regulated by integrin-mediated cell adhesion [10]. In normal cells,
FAK functions as an important regulator of cell motility,
proliferation and anchorage-dependent cell survival [11,12]. In
many tumor cells and malignant tissue, FAK expression is elevated
[13] and the role of FAK in promoting tumor progression remains
an area of active investigation [14]. Analyses of breast cancer
tumor samples have revealed that elevated FAK expression is
correlated with the development of benign ductal hyperplasia into
invasive carcinomas [15,16]. Src-mediated phosphorylation of
FAK at Y576/Y577 enhances FAK catalytic activity and Src
phosphorylation of FAK at Y925 promotes Grb2 SH2-mediated
binding [12,17]. However, Y925 FAK phosphorylation and Grb2
binding to FAK remain unproven as a bona fide linkage
promoting mitogen-activated protein kinase (MAPK) activation
[18–21]. Moreover, a role for intrinsic FAK activity or Y925 FAK
tyrosine phosphorylation in tumorigenesis remains unknown.
Here we showed that si-RNA-mediated simultaneous down
regulation of uPA, uPAR and cathepsin B either alone or in
combination with irradiation forms avascular tumors by significantly
inhibiting Ang-1, Ang-2, VEGF and Y925-FAK expression both in
vitro and in vivo as compared to pSV; however, pUC showed relatively
more pronounced effect over pU2. Therefore, we continued our
study with pUC. We also discovered that over expression of uPAR
and cathepsin B by FL-uPAR/cathepsin B results in rescued
expression of Ang-1 Ang-2, VEGF, FAK (Y925) and Grb2 in
pUC-transfected meningiomacells. Therefore, our results are the first
to show that pUC inhibits intrinsic FAK (Y925) activity and Grb2
expression and thus reduces tumor angiogenesis and this effect is
reversed by over expression of uPAR and cathepsin B. Our study
suggests that inhibition of uPAR/cathepsin B by pUC could be a
potential therapeutic approach by targeting FAK phosphorylation
and can be used as anti-tumor agents in meningioma.
Results
Effect of ionizing radiation alone and in combination
with pUC and pU2 on angiogenesis in meningioma cell
lines
To assess the effect of ionizing radiation on angiogenesis, both
meningioma cell lines were irradiated at a dose of 5 and 10gy, and in
vitro capillary-like structure formation assay was performed with
human microvascular endothelial cells to examine the importance of
tumor-conditioned medium in the angiogenic process. We observed
that 5gy of irradiation induced angiogenesis in IOMM-Lee when
compared with control (1.5 fold; p,0.05) and 10gy irradiation (1.3
fold) made them radio resistant; however, reduced angiogenesis was
shown by the CH-157MN cells conditioned medium at both the 5gy
(30%) and 10gy (40%) dose in human microvascular endothelial cells
(Fig. 1A, B). We wanted to observe the effect of treatment on
radioresistant and radiosensitive cells and elected to conduct further
experiments with a radiation dose of 5gy for IOMM-Lee and 10 gy
for the CH-157MN cell line. To further test the role of uPA, uPAR
and cathepsin B we silenced these genes by si-RNA-mediated pUC
(uPAR/cathepsin B) and pU2 (uPA/uPAR) constructs. We found a
significant decrease of uPAR in IOMM-Lee, CH-157MN and in vivo
samples when transfected with pUC and pU2 either alone or in
combination with irradiation (Fig. 1C). To determine the effect of
pUC/pU2 bicistronic constructs on angiogenesis of conditioned
medium from meningioma cells, we performed vessel formation assay
in human microvascular endothelial cells (Fig. 1D). Results showed
that si-RNA-mediated bicistronic constructs of uPAR and cathepsin
B (pUC) efficiently reduced angiogenesis compared to pU2 (IOMM-
Lee: 37.5%; CH-157MN: 50%) in both cells. We further studied the
combined effect of these bicistronic constructs and irradiation on the
angiogenesis of cells, and found that combined treatment of pUC+IR
reduced vessel formation in both cell lines when compared with
pSV+IR (IOMM Lee: 75%; CH-157MN: 85%; p,0.05), and
pU2+IR (IOMM Lee: 33%; CH-157MN: 55%) (Fig. 1E). Results
are expressed as mean 6 SD of three independent experiments.
These results also show that angiogenesis enhanced in endothelial
cells by irradiation in conditioned medium of IOMM-Lee cells was
again being suppressed by pUC+IR and pU2+IR; however pUC+IR
was found to be relatively more pronounced.
RNAi-mediated simultaneous down regulation of uPAR
and cathepsin B significantly reduces the expression of
angiogenic molecules compared to pU2 both in vitro and
in vivo
Because the alteration in Ang-1, Ang-2, and VEGF is known to
promote angiogenesis, we evaluated the involvement of these
molecules in transfected cells. Our results indicates that simulta-
neous down regulation of uPAR, and cathepsin B reduced the
expression of angiogenic molecules in IOMM-Lee and in CH-
157MN cells when compared with pSV (IOMM Lee: Ang-1
90%, Ang-2 75%, VEGF 65%; CH-157MN: Ang-1, 90%, Ang-2
80%, VEGF 75%; p,0.05) and pU2 (IOMM Lee: Ang-1 72%,
Ang-2 50%, VEGF 50%; CH-157MN: Ang-1 72%, VEGF 50%).
The combination effect of pUC and irradiation was found to be
more effective when compared with pSV+IR (IOMM Lee: Ang-
1 87%, Ang-2 81%, VEGF 71%; CH-157MN: Ang-1 76%, Ang-
2 88%, VEGF 50% p,0.05) and pU2+IR (IOMM Lee: Ang-1
42%, p,0.05: Ang-2 60%, VEGF 50%; CH-157MN: Ang-1 50%,
Ang-2 50%, VEGF 20%) (Fig. 2A, B). Our in vivo findings suggest
that transfection either alone or in combination with irradiation
reduces the vessel formation in nude mice (Fig. 2C) by reducing
the expression of angiogenic molecules both at the RNA (Fig. 2D)
and protein level (Fig. 2E). We discovered the enhanced
expression of angiogenic molecules in irradiated control at the
protein level (Ang-1: 400%, Ang-2: 20%, VEGF: 350%) when
compared with nonirradiated control, which is again down
regulated by combination treatment of pUC +IR (Ang-1 70%:
Ang-2 58%: VEGF 51%). We also discovered the pronounced
effect of pUC +IR over pU2+IR in downregulation of Ang-1
(25%), while we detected no significant difference in the level of
Ang-2 and VEGF. Results are expressed as mean 6 SD. These
results show that in vivo enhanced expression of angiogenic
molecules by irradiation in pSV has been suppressed by both
pUC+IR and pU2+ IR, however pUC +IR was found to be
relatively more effective (Fig. 2F).
Simultaneous downregulation of uPA, uPAR and
cathepsin-B reduce expression of p-FAK (Y925) and
inhibit its interaction with Grb2 both in vitro and in vivo
Many angiogenesis related genes are transcriptionally regulated
by FAK. FAK mediates angiogenesis through a linear pathway
involving Grb-2, H Ras and MEK1 activation. Because FAK is a
major modulator of angiogenesis, we examined the status of FAK in
transfected meningioma cells along with irradiation. For this, we
conducted western analysis and observed significant increase
(600%; p,0.05) in Y925 phosphorylation of FAK in irradiated
IOMM-Lee cells compared to nonirradiated cells. We also found
that treatment of cells with pUC leads to reduction in the p-FAK
(925) expression when compared with pSV (88%) and pU2 (30%).
In contrast to IOMM-Lee cells, CH-157MN cells show reduced
Y925 FAK expression in irradiated cells compared to non-
irradiated cells (65%). Our in vivo studies revealed increased
uPAR/Cathepsin-B in Angiogenesis
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irradiated controltreated mice (600%; p,0.05). The activated form
of pFAK was down regulated by pUC in combination with
irradiation when compared with pSV+IR (96%; p,0.05) and pU2
+IR (54%) in nude mice (Fig. 3A, B). In vivo immunofluorescence
studies in paraffin embedded tumor sections showed the same
results (Fig. 3C). To test the significance of decreased pY925
phosphorylation and to determine whether FAK forms a signaling
complex with Grb2 in meningioma cells, co-immunoprecipitation
analyses were performed. Since pUC caused more reduction of
Y925, angiogenic molecules and angiogenesis when compared with
pU2, we continued our study with pUC only. The Grb2 association
with FAK was inhibited in pUC-transfected meningioma IOMM-
Lee (20%), CH-157MN (70%) and in tumor sections of nude mice
(75%) when compared with pSV. The combination treatment of
pUC +IR again reduced interaction of p-FAK with Grb2 when
compared with pSV+IR in IOMM-Lee (55%), CH-157MN (40%)
and in nude mice (90%) (Fig. 3D, E). As Grb2 binding to FAK is a
possible link to extracellular signal-regulated kinase, MAP kinase
and H Ras activation, phospho-specific antibodies were used to
evaluate mitogen-activated protein kinase kinase 1 (MEK1) and H
Ras in lysates of pUC transfected meningioma cells. These results
are consistent with the loss of signaling through a FAK-Grb2-Ras-
MEK1 pathway upon simultaneous inhibition of uPAR/cathepsin
B in meningioma cells (Fig. 3).
uPAR/cathepsin B over expression rescues angiogenic
defect of pUC-transfected meningioma both in vitro and in
vivo. To prove that the inhibition of uPAR and cathepsin B
leads to reduced vessel formation, uPAR and cathepsin B were
over-expressed in pUC-transfected cells via co-transfection with
FL-uPAR and FL-cathepsin B. We found rescued uPAR and
cathepsin B (Fig. 4A) expression in nonirradiated pUC-transfected
cells (IOMM-Lee: uPAR 1.8 fold, cathepsin B 1.78 fold; CH-
157MN: uPAR 4.5 fold, cathepsin B 4.75 fold; nude mice: uPAR
Figure 1. Effect of ionizing irradiation either alone or in combination with pUC and pU2 in human meningioma cell lines. (A, B)
Conditioned medium of two meningioma cell lines, IOMM-Lee and CH-157MN, was collected after giving 5 and 10 gy doses of c-rays irradiation.
Human microvascular endothelial cells were seeded in 96-well plates and cultured with conditioned medium of meningioma cells. The cells were
maintained for 48 hrs at 21% O2, washed, fixed, stained with Hema-3, and photographed. The percentages of angiogenic cells were assessed using
Cell Quest software. Columns represent means 6 SD of three independent experiments. *p,0.05, significant difference from pSV (C)1 610
5 IOMM-
Lee and CH-157MN cells were transfected with pSV, pUC and pU2 and cell lysates were subjected to SDS-PAGE, and immunoblot analysis was carried
out to detect uPAR level. Similarly, tissue lysates isolated from nude mice were also subjected for western blotting to detect uPAR expression. (D)
Human microvascular endothelial cells were seeded in 48-well plates and cultured with conditioned medium collected from pSV, pUC and pU2
transfected IOMM-Lee and CH-157MN meningioma cells. The cells were kept in a humidified atmosphere containing 5% CO2 at 37uC for 48 h,
washed, fixed and stained with Hema-3 and photographed. (E) Columns represent means 6 SD of three independent experiments. * and # denotes
p,0.05, significant difference from pSV and pSV+IR, respectively.
doi:10.1371/journal.pone.0017123.g001
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cells (IOMM-Lee: uPAR 3 fold, cathepsin B 3.2 fold; CH-157MN:
uPAR 2 fold, cathepsin B 2.6 fold; nude mice: uPAR 4.8 fold,
cathepsin B 1.65 fold) after co-transfection with FL-uPAR and FL-
cathepsin B (Fig. 4B). Both in vivo and in vitro findings suggest that
co-transfection with FL-uPAR and FL-cathepsin B rescues the
vessel formation in pUC-transfected cells (Fig. 4C).
uPAR/cathepsin over expression rescues expression of
angiogenic molecules in pUC-transfected meningioma both
in vitro and in vivo. We observed that co-transfection with FL-
Figure 2. Simultaneous down regulation of uPA, uPAR and cathepsin B inhibits expression of angiogenic molecules in
meningiomas both in vitro and in vivo. (A) IOMM-Lee and CH-157MN cells were transfected with pSV, pUC and pU2 and irradiated as described
earlier. Equal amounts of protein from control and treated cell lysates were analyzed by western blotting using specific primary antibodies for Ang-1,
Ang-2, and VEGF. GAPDH served as a loading control. (B) Band intensities were quantified by densitometry. Columns represent means 6 SD of three
independent experiments. * and # denotes p,0.05, significant difference from pSV and pSV+IR, respectively (C) Athymic nude mice (n=48, nu/nu, 8
mice for each group) were bred and maintained within a specific pathogen-free environment. Transfected IOMM-Lee cells were implanted with dorsal
skin-fold chamber preparation that contained 2 layers of the membrane on both sides of a ring. This model is characterized by both solid and diffuse
infiltrative growth patterns. Orthotopic tumors were established through intracranial injection of IOMM-Lee cells into brains of athymic nude mice.
Once the control group showed chronic symptoms, the animals were euthanized by cardiac perfusion. RT-PCR (D) and western blotting (E) was
performed on nonirradiated and irradiated control and treated tissue lysates by using specific primers/antibodies (Ang-1, Ang-2, VEGF) for angiogenic
proteins. (F) Band intensities were quantified by densitometry. Columns represent means 6 SD. * and # denotes p,0.05, significant difference from
pSV and pSV+IR, respectively.
doi:10.1371/journal.pone.0017123.g002
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molecules in pUC-transfected IOMM-Lee cells (Ang-1 4.0 fold,
Ang-2 2.0 fold, VEGF 2.0 fold), CH-157MN cells (Ang-1 1.8 fold,
Ang-2 2.8 fold, VEGF 4.16 fold) and in nude mice (Ang-1 1.4 fold,
Ang-2 2.5 fold, VEGF 2.1 fold) (Fig. 5A, B). We also found that
FL-uPAR and FL-cathepsin B rescues the expression of angiogenic
molecules in pUC +IR transfected cells (IOMM-Lee: Ang-1 2.5
fold, Ang-2 3.2 fold, VEGF 2.0 fold; CH-157MN: Ang-1 1.6 fold,
Ang-2 1.5 fold, VEGF 2.4 fold; nude mice: Ang-1 2.5 fold, Ang-
2 1.34 fold, VEGF 1.8 fold) (Fig. 5A, B). This data shows that
over-expression of uPAR and cathepsin B might enhance
angiogenesis in pUC-transfected cells by reversing the inhibitory
effect of pUC on angiogenic molecules.
uPAR/cathepsin B overexpression rescues p-FAK (925)
both in vitro and in vivo
Over expression of uPAR and cathepsin B by FL-uPAR and
FL-cathepsin B rescued p-FAK (925), MEK1 and Grb2 expression
in pUC-transfected IOMM-Lee (p-FAK 3.0 fold, MEK1 2.0 fold,
Grb2 6.0 fold), CH-157MN (p-FAK 3 fold, MEK1 3 fold, Grb2 4
fold; p,0.05) and in nude mice (p-FAK 1.5 fold, MEK1 1.4 fold,
Grb2 3 fold). Similarly, it also rescued expression of p-FAK (925),
MEK1 and Grb2 expression in pUC+IR transfected IOMM-Lee
cells(p-FAK 2 fold, MEK1 2.2 fold, Grb2 2.5 fold; p,0.05), CH-
157MN (p-FAK 2 fold, MEK1 1.6 fold, Grb2 1.5 fold; p,0.05)
and in nude mice (p-FAK 2.5 fold, MEK1 1.5 fold, Grb2 5 fold;
p,0.05) (Fig. 6A, B). These results suggest that simultaneous
down regulation of uPAR and cathepsin B either alone or in
combination with irradiation form avascular tumors by down
regulating FAK(Y925) phosphorylation, which is reversed by the
over expression of uPAR and cathepsin B and thus may facilitate
an angiogenic switch in tumors.
Discussion
The over expression of uPA, uPAR and cathepsin B by
radiation has been detected in various malignancies, including
Figure 3. Y925 phosphorylation of FAK and its interaction with Grb2 is suppressed by simultaneous down regulation of uPA, uPAR
and cathepsin B either alone or in combination with irradiation both in vitro and in vivo. (A) Western blotting was performed on
nonirradiated and irradiated control and treated tissue lysates by using specific p-FAK (925) antibody. (B) Band intensities were quantified by
densitometry. Columns represent means 6 SD of three independent experiments. * and # denotes p,0.05, significant difference from pSV and
pSV+IR, respectively. (C) Immunofluorescence analysis was performed for p-FAK expression in paraffin-embedded tumor sections. Fields with intense
fluorescence were scored for protein expression. (D) To test the significance of decreased pY925 phosphorylation and to determine whether FAK
forms a signaling complex with Grb2 in meningioma cells, co-immunoprecipitation analyses were performed by using antibodies for MEK1, Grb-2,
and H Ras both in vitro and in vivo.( E) Band intensities were quantified by densitometry. Columns represent means 6 SD of three independent
experiments. * and # denotes p,0.05, significant difference from pSV and pSV+IR, respectively.
doi:10.1371/journal.pone.0017123.g003
uPAR/Cathepsin-B in Angiogenesis
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Most of the cellular responses modulated by these proteolytic
networks, including migration, cellular adhesion, differentiation,
proliferation and angiogenesis require transmembrane signaling,
which is mediated by direct contacts of these proteolytic networks
with a variety of extracellular proteins and membrane receptors.
In the literature it has been provided that uPA-uPAR binding
results in the expression of cathepsin B and MMP-9 in monocytic
cells [25] as well as cathepsin B indirectly activates other enzymes
including soluble and receptor bound uPA [26].
As a preliminary assessment of the potential of RNAi-mediated
two bicistronic constructs uPAR/cathepsin B (pUC) and uPA/
uPAR (pU2) as a therapeutic agent in this setting, we assessed their
in vitro and in vivo angiogenic activity against primary meningioma
cells. When transfected with bicistronic constructs, meningioma
cells form an avascular tumor phenotype. This avascular
phenotype was mediated by inhibition of angiogenic molecules.
Among two bicistronic constructs, pUC was found to be the most
effective mediator of angiogenesis both in vitro and in vivo as
confirmed by vessel formation assay when compared with pU2
and pSV. However, the combined treatment of pUC with
irradiation was found to be relatively more effective over pU2+IR
and irradiated control both in vitro and in vivo. We also observed
that pUC and pU2 treated cells showed reductions in cell
proliferation after radiation as compared to the controls and
irradiated control as confirmed by BrdU assay (Fig. S1B). Despite
the increase in angiogenesis, we found reduce cellular proliferation
in irradiated control when compared with nonirradiated control.
The reduction in cell proliferation in irradiated cells versus non-
irradiated cells may be due to DNA damage caused by radiation,
which might enhance delay in progression of the cell cycle. It has
been shown that angiogenesis has inverse correlation with
proliferation while at the same time cellular proliferation has
positive correlation with apoptosis in invasive ductal carcinoma of
breast [27].
Moreover, over expression of uPA, uPAR, or cathepsin B by
tumor cells has been shown [28,29] as has the potent angiogenic
activity of these proteolytic networks in epithelial cells which
prompted us to test the possibility that these proteolytic networks
might regulate FAK expression in meningiomas, a possibility that
has not been previously explored to our knowledge. In this study
we have shown that si-RNA-mediated simultaneous down
Figure 4. Over expression of uPAR and cathepsin B rescues vascular phenotype in meningiomas both in vitro and in vivo. (A)
Nonirradiated and irradiated control and treated tissue lysates collected after co- transfection with FL-uPAR/FL-cathepsin B (FLpU/C) were subjected
to SDS-PAGE. Immunoblot analysis was carried out to detect uPAR and cathepsin level. (B) Band intensities were quantified by densitometry.
Columns represent means 6 SD of three independent experiments. * and # denotes p,0.05, significant difference from pUC and pUC+IR,
respectively. (C) Vessel formation assay was performed in FL-uPAR/FL-cathepsin B (FLpU/C) transfected IOMM-Lee and CH-157MN cells and in nude
mice.
doi:10.1371/journal.pone.0017123.g004
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inhibition of Y397 (figure S1A), Y925 phosphorylation of FAK,
less VEGF secretion, or thus leads to small avascular tumors both
in vitro and in vivo when compared with nonirradiated controls and
pU2. We also found relatively reduced angiogenesis by pUC+IR
when compared with irradiated controls and pU2+IR in IOMM-
Lee, CH-157MN meningioma cells and in nude mice. It has been
shown that targeted deletion of FAK suppressed chemically
induced skin tumor formation in mice [30] and reduced apoptosis
was observed in both normal and tumor cells after FAK deletion
[30,31]. To our knowledge this is the first study showing reduced
expression of p-FAK (Y925) by pUC in meningioma cells both in
vitro and in vivo, which may play a role in tumor suppression by
reduced expression of p-FAK (Y925). Despite correlations between
elevated FAK expression and an aggressive tumor phenotype
[13,32], there is limited information on how FAK signaling
contributes to tumor progression in situ [14]. It has been shown
that FAK inhibition via stable FRNK leads to inhibition of FAK-
Grb2-MAPK-signaling linkage and thus also inhibits VEGF
expression [33]. The biological importance of this FAK-signaling
pathway was confirmed through reconstitution experiments using
Src-transformed FAK-null fibroblasts where point-mutations
affecting FAK catalytic activity or Y925 phosphorylation disrupted
the ability of FAK to promote MAPK- and VEGF-associated
tumor growth [33]. We also found that pUC inhibited a FAK-
Grb2-MEK1-Ras signaling linkage regulating VEGF expression.
These results clearly show the involvement of pUC in inhibiting p-
FAK (Y925) signaling with or without irradiation.
Despite the strong correlations between FAK and tumor
metastasis, the molecular mechanism(s) through which FAK can
promote these events has yet to be established. Analyses of FAK
expression levels in esophageal squamous cell carcinoma [34],
hepatocellular carcinoma [35], acute myeloid leukemia [36] and
ovarian cancer [37] tissue samples have found that FAK
expression levels are inversely correlated with patient survival.
Taken together with the fact that FAK catalytic activity promotes
tumor metastasis, the above mentioned studies strongly support
the therapeutic targeting of FAK in the treatment of cancer [33].
As pUC is inhibiting Y925 phosphorylation, we over-expressed
uPAR and cathepsin B by FLpU/C to demonstrate the role of
these molecules in relation to Y925 phosphorylation. The
biological importance of this FAK-signaling pathway was
confirmed through reconstitution experiments using FL-uPAR/
cathepsin B-transformed meningioma cells where overexpression
of uPAR and cathepsin B rescued Y925 phosphorylation, MEK1,
Grb2, Ang-1, Ang-2 and VEGF expression. We also found the
increase in cellular proliferation in pUC transfected cells in both
meningioma cell lines upon overexpression of uPAR and cathepsin
by FL-uPAR/FL-cathepsin B (FLpU/C) as confirmed by BrdU
assay (figure S1C). Since catalytic activity of FAK promotes tumor
Figure 5. Over expression of uPAR and cathepsin B rescues angiogenic molecules. (A) After co-transfection with FL-uPAR/FL-cathepsin B
(FLpU/C), western blotting was performed on nonirradiated and irradiated control and treated tissue lysates by using specific antibodies (Ang-1, Ang-
2, VEGF) for angiogenic proteins. (B) Band intensities were quantified by densitometry. Columns represent means 6 SD of three independent
experiments. * and # denotes p,0.05, significant difference from pUC and pUC+IR, respectively.
doi:10.1371/journal.pone.0017123.g005
uPAR/Cathepsin-B in Angiogenesis
PLoS ONE | www.plosone.org 7 February 2011 | Volume 6 | Issue 2 | e17123angiogenesis, these results strongly support the therapeutic
targeting of FAK by pUC in the treatment of meningioma.
Materials and Methods
Ethics Statement
The Institutional Animal Care and Use Committee of the
University Of Illinois College Of Medicine at Peoria, Peoria, IL,
USA, approved all surgical interventions and post-operative
animal care. The consent was written and approved. The
approved protocol numbers are 817 dated November 1, 2007
and renewed on May 13, 2010, and 851, dated April 23, 2009 and
renewed on May 12, 2010.
Construction of siRNA and FL-uPAR/cathepsin B-
expressing plasmids
Two bicistronic constructs expressing shRNA for uPAR/
cathepsin B (pUC) and uPA/uPAR (pU2) were constructed using
a pcDNA3 vector as described previously by our group [5]. All of
the vectors were expressed under the control of a CMV promoter
[5]. A pcDNA3-scrambled vector with an imperfect sequence,
which does not form a perfect hairpin structure, was used to
develop the scrambled vector for use as a control (pSV). uPAR and
cathepsin B over expressing plasmids were purchased from
OriGene (Rockville, MD).
Cell cultures and transfection conditions and reagents
IOMM-Lee and CH-157MN meningioma cells were purchased
from American Type Culture Collection. Both cell lines were
cultured in high glucose containing Dulbecco’s Modified Eagle’s
Medium. Cultures were supplemented with 100 mg/mL strepto-
mycin, 100 U/mL penicillin and 10% fetal calf serum (FCS) and
maintained in a humidified atmosphere containing 5% CO2 at
37uC. Cells were transfected with pSV, pUC, pU2, FL-uPAR/FL-
cathepsin B (FLpU/C) using Fugene reagent following the
manufacturer’s instructions. Transfected cells were maintained in
serum containing media for 48 h and for irradiated experiments
transfected cells were further irradiated for 24 hour before use in
various procedures. The primary antibodies used for this study
were anti-uPAR (R&D systems, Minneapolis, CH-157MN), p-
FAK, Cathepsin B, Ang-1, Ang-2, VEGF, H Ras (Santa Cruz
Biotechnology, Santa Cruz, CA), MEK1, Grb2, anti-GAPDH
(Cell Signaling, Boston, MA) and HRP conjugated secondary
antibodies (Biomed, Foster City, CA).
In vitro angiogenesis assay
Tumor conditioned medium induced microtubule network
formation was determined as described previously [7]. Irradiated
and non irradiated pUC and pU2 transfected cells were incubated
in serum-free medium in a humidified atmosphere containing 5%
CO2 at 37uC for 24 h. Conditioned medium was collected and
Figure 6. Over expression of uPAR and cathepsin B rescues Y925-FAK phosphorylation. (A) After co-transfection with FL-uPAR/FL-
cathepsin B (FLpU/C) western blotting was performed on nonirradiated and irradiated control and treated tissue lysates by using specific antibodies
(Y925-FAK, MEK1 and Grb2) (B) Band intensities were quantified by densitometry. Columns represent means 6 SD of three independent experiments.
* and # denotes p,0.05, significant difference from pUC and pUC+IR, respectively.
doi:10.1371/journal.pone.0017123.g006
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derived from dermis and provided by Dr. Francisco J. Candal
(Centers for Disease Control and Prevention, Atlanta, GA, USA),
which were seeded the previous day in 48-well plates and
incubated for 48 hour. The formation of the microtubule networks
was examined using a phase-contrast microscope equipped with a
CC camera and evaluated by Discovery Image Pro software
(Fryer, Huntley, IL). All experiments were repeated at least three
times. The degree of angiogenesis was measured by the following
method: number of branch points and the total number of
branches per point were counted, with the product indicating the
degree of angiogenesis.
Results are presented as the means 6 SD of eight fields.
Western blot analysis
All meningioma cells were cultured in 100-mm dishes. The cells
were transfected with bicistronic constructs pUC, pU2 and FL-
uPAR/FL-cathepsin B (FLpU/C) for 48 h. At the same time,
control cultures were maintained in 21% O2 for 48 hours. For
irradiation experiments transfected cells were irradiated for further
24 hours. Cell extracts were prepared in ice-cold RIPA buffer
(50 mmol/L Tris-HCl (pH 7.4), 150 mmol/L NaCl, 1% IGEPAL,
1 mmol/L EDTA, 0.25% sodium deoxycholate, 1 mmol/L
sodium fluoride, 1 mmol/L sodium orthovanadate, 0.5 mmol/L
PMSF, 10 mg/mL aprotinin, 10 mg/mL leupeptin). The protein
concentration in each extract was determined by BSA assay
(Sigma, St. Louis, MO). Cell extracts were subjected to SDS-
PAGE and proteins were transferred to nitrocellulose membranes
and probed with primary antibodies that detect Ang-1, Ang-2,
VEGF, p-FAK, MEK1, H Ras, uPAR, cathepsin B and Grb2.
Signals were detected by using the ECL system (Amersham
Bioscience). The same membranes also were probed to detect
GAPDH as a loading control.
Immunofluorescence analysis of protein expression in
tumor sections
Paraffin-embedded tumor sections were subjected to rehydra-
tion by passing through a series of xylene, 100% and 90% ethanol.
The slides were washed in cold PBS and blocked for 30 min in 1%
BSA prepared in PBS followed by overnight incubation in primary
antibody (p-FAK-Y925) at a concentration of 1:100 at 4uC. The
slides were then washed three times with 1% BSA in PBS for
2 min per wash, and incubated for 1 hr in appropriate
fluorescence-labeled secondary antibody. The slides were kept in
the dark to avoid exposure to light. Preparations were mounted on
slides using DAPI (Sigma, St. Louis, MO) and fields with intense
fluorescence were scored for protein expression. All microscopy
studies were performed using fluorescent microscope attached to
Olympus camera and set to auto.
Dorsal skin-fold chamber model
Athymic nude mice (nu/nu; 48 female, 5–7 weeks old) were
divided into 8 treatment groups with 6 animals in each group and
maintained within a specific pathogen and germ-free environment.
The implantation technique of the dorsal skin-fold chamber model
has been described previously [38]. Sterile small-animal surgical
techniques were followed. Mice were anesthetized by intraperito-
neal injection with ketamine (50 mg/kg)/xylazine (10 mg/kg).
Once the animal was anesthetized completely, a dorsal air sac was
made in the mouse by injecting 10 mL of air. Diffusion chambers
(Fisher, Hampton, NH) were prepared by aligning 0.45-mm
Millipore membranes (Fisher) on both sides of the rim of the ‘‘O’’
ring (Fisher) with sealant. Once the chambers were dry (2–3 min),
they were sterilized by UV radiation overnight. Membranes were
wetted with 20 mL of PBS. 5610
6 pSV/pUC/pU2 and FLuPAR/
cathepsin B transfected cells either alone or in combination with
irradiation were suspended in 100–150 mL of sterile PBS and
injected into the chamber through the opening of the ‘‘O’’ ring.
The opening was sealed with a small amount of bone wax. A 1.5 to
2 cm superficial incision was made horizontally along the edge of
the dorsal air sac and the air sac was opened. With the help of
forceps, the chambers were placed underneath the skin and
carefully sutured. After 15 days, the animals were anesthetized
with ketamine/xylazine and sacrificed by intracardial perfusion
with saline (10 mL) followed by 10 mL of 10% formalin/0.1 M
phosphate solution. The animals were carefully skinned around
the implanted chambers and the implanted chambers were
removed from the subcutaneous air fascia. The skin fold covering
the chambers was photographed under visible light.
Reverse transcription-PCR
Total RNA was extracted using TRIZOL reagent (Life
Technologies,Carlsbad, California) according to the manufactur-
er’s instructions. RT-PCR was done by using the reverse
transcription kit (Roche Diagnostics, Indianapolis, IN). PCR
products were resolved on 1.5% agarose gel and seen by ethidium
bromide staining. b actin was used as loading control. We used the
following primers:
Ang-1, Forward 59-GAAGGGAACCGAGCCTATTC-39, and
reverse 59 GGGCACATTTGCACATACAG
Ang-2, forward 59-CCACAAATGGCATCTACACG-39, and
reverse 59- CCCAGCCAATATTCTCCTGA-39;
VEGF forward 59- ATGAACTTTCTGCTGTCTTGGGT -
39, and reverse 59- TCACCGCCTCGGCTTGTCAC -39;
b actin, forward 59-GTCGTACCACTGGCATTGT-39, and
reverse 59- CAGCTGTGTGGTGGTGAAGCT -39.
PCR products were resolved on 1% agarose gel, visualized, and
photographed under UV light. RT-PCR for b actin was
performed to normalize input RNA.
Immunoprecipitation
Meningioma cells were grown in 100 mm plates, transfected
with pSV & pUC either alone or in combination with irradiation
and lysed in 1 ml of immunoprecipitation buffer for 30 min on ice,
with occasional swirling. One ml of immunoprecipitation buffer
lacking detergent was then added to each plate and cells were
scraped. The following immunoprecipitation buffer was used:
60.5% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesul-
fonic acid, 150 mM NaCl, 50 mM Tris-Hcl, 2 mM EDTA,
2 mM EGTA, 2 mM Na3VO4,2 mM DTT, and protease
inhibitor mixture. Cells then were spun for 20–30 min at
20,0006g, and the supernatants were used. Antibodies for FAK
were added at a dilution of 1:100 to a total of 1 ml and
immunoprecipitations were performed at 4uC overnight with
constant mixing. Fifty to 100 ml of protein A or G beads were
added, and the solution was allowed to mix for 1–3 h at 4uC.
Immunoprecipitations were washed using the immunoprecipita-
tion buffer 4x and then brought up in 2x Laemli buffer for protein
electrophoresis and Western blot analysis. Supernatants were
loaded at one-fiftieth the volume of the pellet.
Establishment and treatment of orthotopic intracranial
tumors in athymic nude mice
Orthotopic tumors were established through intracranial
injection of tumor cells into brains of athymic nude mice. Six
animals were used for each group. IOMM-Lee cells were grown in
uPAR/Cathepsin-B in Angiogenesis
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0.1 million cells were injected into anesthetized nude mice
(50 mg/kg ketamine, 10 mg/kg xylazine) using a stereotactic
frame.
The animals were maintained for one week to allow the tumors
to develop and then divided into 8 treatment groups with 6
animals in each group. Alzet mini-osmotic pumps (Durect
Corporation, Cupertino, CA) containing 150 mg of plasmid at a
concentration of 1.5 mg/mL were set up for each animal. The
animals were treated with pSV, pUC, pU2 and FLuPAR/
cathepsin B with or without irradiation and allowed to grow for 3
to 4 weeks. Once the control group showed chronic symptoms, the
animals were euthanized by cardiac perfusion—first using PBS
followed by 10% phosphate-buffered formalin. The brains were
removed and stored in 10% phosphate-buffered formalin and
embedded in paraffin as per standard protocol [39].
Densitometry. Densitometry was performed by using Image
J Software (NIH) to quantify the band intensities obtained from
western blot and RT-PCR. Data represent values of three separate
experiments.
Statistical analysis. All data here are presented as means 6
SD of at least three independent experiments, each performed in
triplicate. One-way analysis of variance (ANOVA) combined with
the Tukey post hoc test of means were used for multiple
comparisons in cell culture experiments. Differences in the
values were considered significant at p,0.05.
Supporting Information
Figure S1 Simultaneous downregulation of uPA, uPAR
and cathepsin-B reduce expression of p-FAK (Y925),
inhibits cellular proliferation and over expression of
uPAR and cathepsin B rescues cellular proliferation in
meningiomas.
(TIF)
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